Effect of Cilostazol on the Pharmacokinetics of Simvastatin

NCT01383395 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-05-20

No results posted yet for this study

Summary

To evaluate the effect of cilostazol on the pharmacokinetics of simvastatin in healthy adult subjects.

Conditions

  • Healthy

Interventions

DRUG

simvastatin/cilostazol

Sponsors & Collaborators

  • Inje University

    collaborator OTHER
  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • JaeWook Ko, MD · Samsung Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
48 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01383395 on ClinicalTrials.gov